Mineralys Therapeutics MLYS Balance Sheet (2022-2026)

NASDAQ MLYS
$15.52 -0.29 (-1.83%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Mineralys Therapeutics Quarterly Balance Sheet

Periods 19 quarters
Latest Sep 2026

Mineralys Therapeutics reported total assets of $630.12M and total liabilities of $126.35M for the quarter ended Sep 2026, up 5.0% year over year. This balance sheet covers 19 quarters of results from Mar 2022 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 87.70M138.25M101.14M86.30M49.30M90.42M67.86M97.27M114.09M165.01M101.79M217.60M172.92M112.78M138.27M101.27M
Short-term InvestmentsInvestments (Current) 22.41M132.39M159.96M167.46M187.26M248.15M243.26M166.33M84.10M178.02M223.13M376.03M483.71M533.30M523.14M523.40M
Cash & Current Investments 110.11M270.64M261.10M253.76M236.57M338.57M311.12M263.60M198.19M343.03M324.92M593.63M656.64M646.08M661.41M624.67M
Prepaid Assets 2.70M4.64M8.39M11.61M12.54M8.25M6.89M4.13M7.16M11.48M10.35M6.17M4.75M6.41M4.39M3.32M
Current Assets 112.81M275.27M269.49M265.38M249.10M346.82M318.00M267.73M205.35M354.51M335.27M599.80M661.39M652.47M665.80M627.99M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net) 0.05M0.04M0.07M0.05M0.04M0.02M0.01M0.04M0.03M0.03M0.02M
Long-Term Investments 31.12M21.68M12.13M2.48M
Other Non-Current Assets 1.63M0.04M0.05M0.05M0.05M0.38M0.45M0.45M0.50M0.40M0.43M0.14M0.38M0.36M2.02M2.11M
Non-Current Assets 1.63M31.16M21.73M12.18M2.53M0.43M0.49M0.52M0.55M0.44M0.46M0.15M0.42M0.39M2.05M2.13M
Assets 114.44M306.44M291.22M277.56M251.64M347.25M318.49M268.25M205.90M354.94M335.72M599.95M661.81M652.86M667.85M630.12M
Liabilities
Current Liabilities
Accounts Payables 1.91M2.39M2.20M5.57M0.60M4.26M1.71M3.11M0.48M0.37M3.16M1.12M2.02M1.12M1.07M0.74M
Payables 1.91M2.39M2.20M5.57M0.60M4.26M1.71M3.11M0.48M0.37M3.16M1.12M2.02M1.12M1.07M0.74M
Accumulated Expenses 6.16M8.17M4.01M7.97M9.88M14.94M26.69M28.22M14.17M13.01M19.01M22.40M13.10M13.60M18.25M27.34M
Total Current Liabilities 53.08M
Short term Debt 25.00M
Non-Current Liabilities
Non-Current Debt 73.27M
Preferred Stock Liabilities 40.99M158.64M158.64M158.64M
Total Liabilities 126.35M
Shareholder's Equity
Total Debt 98.27M
Common Equity 503.78M
Liabilities and Shareholders Equity 630.12M
Retained Earnings -794.91M

Mineralys Therapeutics Balance Sheet API

Pull Mineralys Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MLYS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY